Literature DB >> 19372016

Hormonal changes during menopause.

Farook Al-Azzawi1, Santiago Palacios.   

Abstract

Ovarian senescence occurs gradually during the fourth and fifth decades of life, leading to menopause at an average age of about 51 years. This senescence results in a changing hormonal milieu, with decreases in the levels of estrogens and androgens. Similar changes may be induced by surgical menopause (bilateral oophorectomy) or ovarian failure resulting from cancer treatment. The declining levels of estrogens and androgens affect many tissues of the body and can produce a variety of signs and symptoms, including vasomotor symptoms, decreased bone density, changes in mood and energy, loss of pubic hair and changes in the genital tissues, and effects on sexual function. Accurate measurement of testosterone levels in postmenopausal women requires methods that are validated in the lower ranges of testosterone level observed in this population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372016     DOI: 10.1016/j.maturitas.2009.03.009

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  31 in total

1.  Modeling perimenopause in Sprague-Dawley rats by chemical manipulation of the transition to ovarian failure.

Authors:  Jennifer B Frye; Ashley L Lukefahr; Laura E Wright; Sam L Marion; Patricia B Hoyer; Janet L Funk
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

Review 2.  Effects of training on bone mass in older adults: a systematic review.

Authors:  A Gómez-Cabello; I Ara; A González-Agüero; J A Casajús; G Vicente-Rodríguez
Journal:  Sports Med       Date:  2012-04-01       Impact factor: 11.136

Review 3.  Gender differences, aging and hormonal status in mucosal injury and repair.

Authors:  Irina Grishina; Anne Fenton; Sumathi Sankaran-Walters
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

4.  Menopausal symptoms and the risk of young-onset breast cancer.

Authors:  Chunyuan Fei; Lisa A DeRoo; Dale P Sandler; Clarice R Weinberg
Journal:  Eur J Cancer       Date:  2012-09-27       Impact factor: 9.162

5.  Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension.

Authors:  Erin J Aiello Bowles; Melissa L Anderson; Susan D Reed; Katherine M Newton; E Dawn Fitzgibbons; Deborah Seger; Diana S M Buist
Journal:  J Womens Health (Larchmt)       Date:  2010-08       Impact factor: 2.681

6.  Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal women.

Authors:  Farzana Choudhury; Leslie Bernstein; Howard N Hodis; Frank Z Stanczyk; Wendy J Mack
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

7.  Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.

Authors:  Sara E Looby; Kathleen V Fitch; Suman Srinivasa; Janet Lo; Danielle Rafferty; Amanda Martin; Judith C Currier; Steven Grinspoon; Markella V Zanni
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

8.  Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older.

Authors:  Anne Marie McCarthy; Andy Menke; Pamela Ouyang; Kala Visvanathan
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-03

9.  Effects of aerobic exercise on urinary estrogens and progestagens in pre and postmenopausal women.

Authors:  María Concepción Robles Gil; R Timón; A F Toribio; D Muñoz; J I Maynar; M J Caballero; M Maynar
Journal:  Eur J Appl Physiol       Date:  2011-05-11       Impact factor: 3.078

10.  Age and sex related differences in subcortical brain iron concentrations among healthy adults.

Authors:  Ninni Persson; Jianlin Wu; Qing Zhang; Ting Liu; Jing Shen; Ruyi Bao; Mingfei Ni; Tian Liu; Yi Wang; Pascal Spincemaille
Journal:  Neuroimage       Date:  2015-07-26       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.